Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers a...
-
Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Stomach Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. This report provides insights into market dynamics, trends,...
-
Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Throat Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The throat cancer market has exhibited significant growth...
-
Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Adrenocortical Carcinoma Market Report 2026" has been added to ResearchAndMarkets.com's offering. The adrenocortical carcinoma market is on a...
-
In 2025, muzastotug showed 29% confirmed overall response rate (ORR) among 21 patients with MSS CRC in the 20 mg/kg dose cohorts Median overall survival (OS) for the 10 mg/kg cohorts was 19.4...
-
Le Rezurock de Sanofi approuvé dans l’UE pour le traitement de la maladie chronique du greffon contre l’hôte Rezurock est maintenant approuvé dans l’UE pour les adultes et les enfants âgés de 12 ans...
-
Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease Rezurock is now approved in the EU for adults and children aged 12 years and older with chronic GVHD, providing a new...
-
PRINCETON, N.J. and SUZHOU, China, March 30, 2026 (GLOBE NEWSWIRE) -- Transcenta Therapeutics (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in...
-
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Cutaneous Squamous Cell Carcinoma (cSCC) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The cutaneous squamous cell...
-
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Pancreatic Adenocarcinoma Treatment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The pancreatic adenocarcinoma...